These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2856783)

  • 1. Effects of calcium entry blockers on calcium fluxes in a vascular smooth muscle cell line.
    Rüegg UT; Doyle VM; Hof RP
    J Hypertens Suppl; 1985 Dec; 3(3):S57-9. PubMed ID: 2856783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The voltage-dependent non-selective cation channel sensitive to the L-type calcium channel blocker efonidipine regulates Ca2+ influx in brain vascular smooth muscle cells.
    Matsuoka T; Nishizaki T; Nomura T
    Biochem Biophys Res Commun; 1997 Nov; 240(2):484-7. PubMed ID: 9388505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta.
    Hof RP; Scholtysik G; Loutzenhiser R; Vuorela HJ; Neumann P
    J Cardiovasc Pharmacol; 1984; 6(3):399-406. PubMed ID: 6202964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of sodium-calcium exchange and effects of calcium entry blockers on endothelial-mediated responses in rat isolated aorta.
    Schoeffter P; Miller RC
    Mol Pharmacol; 1986 Jul; 30(1):53-7. PubMed ID: 3014308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AT1 receptors and L-type calcium channels: functional coupling in supersensitivity to angiotensin II in diabetic rats.
    Arun KH; Kaul CL; Ramarao P
    Cardiovasc Res; 2005 Feb; 65(2):374-86. PubMed ID: 15639476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blockers: correlation among receptor binding, calcium uptake and contractility in vitro.
    Papaioannou S; Panzer-Knodle S; Yang PC
    J Pharmacol Exp Ther; 1987 Apr; 241(1):91-6. PubMed ID: 3572800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of calcium entry in smooth muscle cells by the antidepressant imipramine.
    Becker B; Morel N; Vanbellinghen AM; Lebrun P
    Biochem Pharmacol; 2004 Sep; 68(5):833-42. PubMed ID: 15294446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of dihydropyridine calcium antagonists on early growth response gene expression and cell growth in vascular smooth muscle cells.
    Ko Y; Totzke G; Graack GH; Heidgen FJ; Meyer zu Brickwedde MK; Düsing R; Vetter H; Sachinidis A
    J Hypertens; 1993 Nov; 11(11):1171-8. PubMed ID: 8301097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel high affinity class of Ca2+ channel blockers.
    Qar J; Barhanin J; Romey G; Henning R; Lerch U; Oekonomopulos R; Urbach H; Lazdunski M
    Mol Pharmacol; 1988 Apr; 33(4):363-9. PubMed ID: 2965787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
    Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H
    Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium entry blockers and vascular smooth muscle heterogeneity.
    Van Nueten JM; Vanhoutte PM
    Fed Proc; 1981 Dec; 40(14):2862-5. PubMed ID: 7308496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of DNA synthesis induced by platelet-derived growth factor by tranilast, an inhibitor of calcium entry, in vascular smooth muscle cells.
    Nie L; Mogami H; Kanzaki M; Shibata H; Kojima I
    Mol Pharmacol; 1996 Oct; 50(4):763-9. PubMed ID: 8863820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of action of Ca++ entry blockers. A comparison of their actions in rat arteries and in human coronary arteries.
    Godfraind T; Miller RC
    Circ Res; 1983 Feb; 52(2 Pt 2):I81-91. PubMed ID: 6831654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advance in calcium channel blockers relaxing corpus cavernosum smooth muscle].
    Xiao HJ; Liu JH
    Zhonghua Nan Ke Xue; 2003 Feb; 9(1):55-7. PubMed ID: 12680335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some recent pharmacological findings with nitrendipine.
    Scriabine A; Anderson CL; Janis RA; Kojima K; Rasmussen H; Lee S; Michal U
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S937-43. PubMed ID: 6085381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actions of 8-(N,N-diethylamino)-n-octyl-3,4,5-trimethoxybenzoate in vascular smooth muscle cell cultures.
    Chen Z; Liu SX; Chiou GC
    Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):299-303. PubMed ID: 10072908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for capacitative and non-capacitative Ca2+ entry pathways coexist in A10 vascular smooth muscle cells.
    Zhou JG; Qiu QY; Zhang Z; Liu YJ; Guan YY
    Life Sci; 2006 Feb; 78(14):1558-63. PubMed ID: 16236332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of L-type calcium channel in myocardium and calcium-induced contractions of vascular smooth muscle by CPU 86017.
    Dai DZ; Hu HJ; Zhao J; Hao XM; Yang DM; Zhou PA; Wu CH
    Acta Pharmacol Sin; 2004 Apr; 25(4):416-23. PubMed ID: 15066206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on calcium antagonistic and alpha 1-adrenergic receptor blocking activities of monatepil maleate, its metabolites and their enantiomers.
    Honda Y; Masuda Y; Yoshida T; Sato F; Kurokawa M; Hosoki K
    Arzneimittelforschung; 1995 Oct; 45(10):1057-60. PubMed ID: 8595057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.